Global Biopharmaceutical Contract Manufacturing Market

Global Biopharmaceutical Contract Manufacturing Market Size, Share, and COVID-19 Impact By Service (Process Development), By Drug Type (Biologics, Biosimilars), and By Region (North America, Europe, Asia-Pacific, Latin America, Middle East, and Africa), Analysis and Forecast 2023 - 2033

Release Date
Aug 2025
Report ID
DAR1640
Pages
240
Report Format

Global Biopharmaceutical Contract Manufacturing Market Overview

  • The Global Biopharmaceutical Contract Manufacturing Market Size was worth around?USD 36.09 Billion?in 2023 and is predicted to grow to around?USD 102.99 Billion by 2033 with a compound annual growth rate?(CAGR)?of 11.06%?between 2023 and 2033.
  • The market growth is rising due to driven by the increasing number of biologics, the need for sophisticated therapeutics to cure chronic diseases, improvements in manufacturing technologies, and continuous regulatory reforms in a number of economies.
  • The biopharmaceutical contract manufacturing market refers to the industry that the contract manufacturing of biopharmaceutical products by third-party specialist companies, called Contract Development and Manufacturing Organizations (CDMOs).

Global Biopharmaceutical Contract Manufacturing Market

Major vendors in the Global Biopharmaceutical Contract Manufacturing Market

Toyobo Co. Ltd., Samsung Biologics, Thermo Fisher Scientific, Inc., Binex Co., Ltd., WuXi Biologics, AbbVie, Inc., ADMA Biologics, Inc., Catalent, Inc, Cambrex Corporation, Pfizer Inc., Siegfried Holding AG, and Others.

Market Segment

This study forecasts revenue at the global, regional, and country levels from 2023 to 2033. Decision Advisors has segmented the biopharmaceutical contract manufacturing market based on the below-mentioned segments:

Global Biopharmaceutical Contract Manufacturing Market

Global Biopharmaceutical Contract Manufacturing Market, By Service

  • Process Development

Global Biopharmaceutical Contract Manufacturing Market, By Drug Type

  • Biologics
  • Biosimilars

Global Biopharmaceutical Contract Manufacturing Market, By Regional Analysis

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • France
    • Italy
    • Spain
    • Russia
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Rest of Asia Pacific
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Middle East & Africa
    • UAE
    • Saudi Arabia
    • Qatar
    • South Africa
    • Rest of the Middle East & Africa

Request Table of Contents:

Check Licence

Choose the plan that fits you best: Single User, Multi-User, or Enterprise solutions tailored for your needs.

Report Details

Pages 240 pages
Delivery PDF & Excel, via Email
Language English
Request Discount  

15% Free Customization

Share your requirements

Request Customization  

We Have You Covered

  • 24/7 Analyst Support
  • Clients Across the Globe
  • Tailored Insights
  • Technology Tracking
  • Competitive Intelligence
  • Custom Research
  • Syndicated Market Studies
  • Market Overview
  • Market Segmentation
  • Growth Drivers
  • Market Opportunities
  • Regulatory Insights
  • Innovation & Sustainability

Report Details

Pages 240
Delivery PDF & Excel via Email
Language English
Release Aug 2025
Access Download from this page
Request Sample